We are proud to announce that MyCognition has been selected as a participant to the East Midlands Digital Health Accelerator programme 2019.
The East Midlands accelerator is one of five recently launched across England – building on the successful DigitalHealthLondon Accelerator. The schemes are run by the Academic Health Science Networks (AHSNs), the innovation arm of the NHS, and their partners. Launched in May 2019, the East Midlands Digital Health Accelerator programme has been created to speed up the adoption of technology within the NHS and support innovative digital health businesses.
Following its successful application, MyCognition will be supported through the programme to help tackle the NHS’s most pressing challenges – reducing the burden mental health and the currents gaps in mental health care, while helping patients with long-term conditions to improve their cognitive functioning and self-management. MyCognition will receive specialist training, one-to-one support and opportunities to showcase their products with NHS decision-makers and influencers.
MyCognition is an R&D based business dedicated to understanding, tracking and strengthening cognitive fitness through digital technology. MyCognition’s vision developed from a desire to improve the mental health and quality of life of individuals with cognitive deficits associated with ageing, clinical diagnosis and societal factors. Co-designed with patients, the MyCognition PRO app enables people to correct and improve their cognitive functioning, strengthen their mental resilience and increase their productivity. Providing healthcare organisations with welcomed innovative technology to better manage patients in less expensive clinical and care settings such as community care and their own homes.
Since 2012 MyCognition has invested £5M to design and develop solutions validated and tested in clinical trials and real-world studies nationally and internationally, with leading Universities and renowned academics, including over 20,000 users across all ages and different health conditions. Our technology is regulated by the MHRA as CE marked Class 1a Medical Device. It is approved by worldwide leading assessors of health apps, NHS Digital and ORCHA, for use in clinical care settings to measure and improve cognitive functioning. MyCognition has an extensive ongoing clinical development programme underway with number SME and Academic consortia and NHS bodies.
Keiron Sparrowhawk, CEO at MyCognition, comments: “Being part of this DHA is a big deal for us at MyCognition and is the next step in our vision to positively change the world one mind at a time.”
Michael Morgan-Curran, Commercial and Clinical Development, “We are delighted to be part of the East Midlands AHSN DHA helping us spread the adoption and spread of MyCognition so that healthcare professionals can better care for the cognitive health of their patients.“
EMAHSN Commercial Director Tim Robinson says: “We’re delighted to be working with these five digital health companies as part of our Digital Health Accelerator. We have selected them on to our scheme because we feel their innovation can make a real difference to health and care. We are in a unique position within the health and care system, placed between the NHS and industry, and we can use this position to support our innovators to maximise adoption and spread of their products.”